NIH-funded research R15 grant

Protein Kinase R and hantavirus organ targeting in humans

Official title: Protein Kinase R's Role in Hantavirus Organ Tropism

Funded at Western University of Health Sciences · NIH-11358667 · Data updated 2026-11-12

Researchers are studying how PKR and related proteins influence where hantaviruses attack in the body, which could lead to better protection against kidney and heart/lung damage in people exposed to these viruses.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionWestern University of Health Sciences
NIH-funded
Lab location1 site (Pomona, United States)
Project startJuly 1, 2026
Project endJune 30, 2029
Funding year2026
Award (this year)$540,000
NIH project number1R15AI194198-01A1
Project IDNIH-11358667 on NIH RePORTER

Who could benefit from this research

Could help

Patients at risk for hantavirus exposure or those with hantavirus-related organ complications could benefit from advances in targeted therapies, diagnostics, or prevention strategies.

Less likely to help

Individuals without exposure risk or without hantavirus infection may not directly benefit from this basic mechanistic study.

What this research studies

This project examines how hantaviruses interact with human endothelial cells in the kidney and heart, focusing on the role of PKR and the P58IPK inhibitor to understand why certain organs are targeted. It uses cell-based experiments to test how viral proteins affect PKR activity and viral replication, with implications for preventing organ failure. The work aims to identify molecular pathways that control tissue tropism and disease severity in hantavirus infections. Findings could inform future therapeutic strategies to reduce kidney injury and cardiopulmonary distress in patients.

Why it matters

Potential benefit: If successful, the research could inform new approaches to prevent or lessen kidney and heart/lung complications from hantavirus infections.

How similar studies have gone: Previous work has shown that PKR pathways can influence hantavirus replication, supporting potential translational relevance of this approach.

Where this research is happening

  • Western University of Health Sciences
    Pomona, United States
    Active

Researchers

  • Principal investigator: Mir, Sheema — Western University of Health Sciences
  • Study coordinator: Mir, Sheema

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.